Michael Gelband’s Apollo Endosurgery, Inc. APEN Stock Holding History

Michael Gelband’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-48,933	Closed	-$485K	–	2370
2023 Q1	$485K	Buy	+48,933	New	+$485K	﹤0.01%	1348
2022 Q2	–	Sell	-10,540	Closed	-$64K	–	2672
2022 Q1	$64K	Sell	10,540 -3,888	-27%	-$23.7K	﹤0.01%	2044
2021 Q4	$122K	Buy	+14,428	New	+$126K	﹤0.01%	1923

Michael Gelband's APEN Position: Q2 2023 in Review

Michael Gelband sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 48,933 shares — an estimated $485K sold.

Michael Gelband first reported a position in APEN in Q4 2021 and held it in 3 quarters. The position peaked at $485K in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Michael Gelband reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Michael Gelband sold 48,933 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $485K.
Michael Gelband first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 3 quarters.
Michael Gelband's Apollo Endosurgery, Inc. position peaked at $485K in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on ExodusPoint Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.